IMAGINE PHARMA LLC – Trademark Portfolio
Entity Type: 16
IMAGINE PHARMA LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 4 are pending. Notable registered marks include IMG-1, PROGENALEN, and IMAGINE ISLET CENTER. The owner is based in DEVON, PA.
28 S WATERLOO RD, SUITE 100
DEVON, PA 19333
Showing of trademarks Trademarks
Trademark Classifications
IMAGINE PHARMA LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does IMAGINE PHARMA LLC have?
IMAGINE PHARMA LLC has 13 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending, 6 abandoned.
What trademark classes does IMAGINE PHARMA LLC file in?
IMAGINE PHARMA LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are IMAGINE PHARMA LLC's most well-known trademarks?
IMAGINE PHARMA LLC's registered trademark portfolio includes well-known marks such as IMG-1, PROGENALEN, and IMAGINE ISLET CENTER. These are among 3 currently registered trademarks in the portfolio.
What is IMAGINE PHARMA LLC's trademark registration success rate?
IMAGINE PHARMA LLC has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 4 applications are pending review.